Acta Dermato-Venereologica Suppl 219 AbstractPsoriasis2018 | Page 54

52

5 th World Psoriasis & Psoriatic Arthritis Conference 2018

Methods: 101 participants were randomly allocated to a treatment arm( MBCT) or a TAU arm. Participants were measured pre, posttreatment and after a 3-month follow up period. Data were analysed using intention-to-treat analysis and the ANCOVA method with baseline scores entered as covariates. Results: There was a significant group × time( pre vs. post) interaction on all variables except QoL, indicating a significant reduction of each variable except QoL over time in the MBCT group, but not in the control group. When baseline variables were controlled for, the participants in the MBCT group achieved small statistically significant changes across all variables post intervention versus the TAU group. Conclusions: The results suggest that MBCT may be a useful adjunct therapy for those suffering from psoriasis and the associated psychological symptoms relating to the condition. The results also indicate that each of the mechanisms outlined in the CBPM change significantly for patients who engage in the intervention.

P127 A MIXED METHODS STUDY EXPLORING THE IMPACT OF MINDFULNESS ON PSORIASIS, ANXIETY,

DEPRESSION AND QOL Alan Maddock, David Hevey School of Psychology, Trinity College Dublin

Introduction: Psoriasis is a common condition with recognised psychological comorbidity. Psoriasis can have a profound impact on a patient’ s life, with the prevalence of anxiety, depression, poor wellbeing and quality of life generally found to be high in psoriasis populations. Based on Buddhist psychology, mindfulness based interventions have been shown to have positive impacts on anxiety, depression, wellbeing and quality of life in various populations. Methods: Mixed methods explored the impact of a mindfulness based cognitive therapy( MBCT) intervention on 10 psoriasis patients using a Buddhist Psychological Model( BPM) as a theoretical framework to understand changes in these variables. Quantitative measures of acceptance, attention regulation, attachment, aversion, self-compassion, mindfulness, rumination, worry, wellbeing, anxiety, depression and psoriasis symptoms were completed pre and post intervention, and participants were interviewed about their experiences of MBCT. Results: Statistically significant changes in attention, mindfulness, attachment, aversion, rumination, quality of life, anxiety and psoriasis were found. The qualitative data provided support for the BPM as a theoretical lens with which to understand the way in which mindfulness impacts on patient quality of life, anxiety and psoriasis symptoms. Conclusions: This study gives support to the promising potential of mindfulness interventions being implemented by mental health care professionals with psoriasis patients.

P128 A LINK BETWEEN QUALITY OF PATIENT-PHYSICIAN COMMUNICATION AND PATIENT HEALTHCARE

NEEDS IN PSA A-M Orbai 1, L Coates 2, VF Azevedo 3, A Garg 4, A Majjhoo 5, CEM Griffiths 6, P Young 7, JC Cappelleri 8, J Moser 9, L Fallon 10

1

Johns Hopkins University School of Medicine, Baltimore, MD, USA,

2

University of Oxford, Oxford, UK, 3 Universidade Federal do Paraná, Curitiba, Brazil, 4 Donald and Barbara Zucker School of Medicine at Hofstra / Northwell, Hempstead, NY, 5 Shores Rheumatology, MI, USA,

6

University of Manchester, Manchester, UK, 7 Pfizer Inc, Collegeville, PA,

8

Pfizer Inc, Groton, CT, 9 The Harris Poll, Rochester, NY, USA, 10 Pfizer Canada, Montréal, QC, Canada

Introduction: Patient( pt)-physician( HCP) communication may influence symptom reporting and disease control. Objectives: To evaluate psoriatic arthritis( PsA) symptoms, life impact and treatment satisfaction in pts who report good communication with their HCP vs suboptimal communication. Methods: An online pt-based survey was conducted in the US from 2 Nov – 1 Dec 2017. Pts had reported having PsA for > 1 year, taken ≥1 synthetic( s) or biologic( b) DMARD for PsA. Pts reported overall health, PsA severity / symptoms / life impact, treatment satisfaction and communication experience. We evaluated differences by pt-HCP communication status. Results: Overall, 301 pts with PsA responded, mean age 45 years, 61 % female, 89 % self-reported moderate / severe PsA. Current PsA treatments included bDMARD( 52 %), sDMARD( 25 %), combination b / sDMARD( 15 %). Overall, 256( 85 %) of PsA pts were managed by a rheumatologist and 15 % by a dermatologist. Of the 256, > 40 % reported suboptimal pt-HCP communication. Pts in the suboptimal vs good communication subgroups were typically younger, more likely to be Hispanic and reported greater life impact and lower satisfaction with pt-HCP communication( Table).

Table. Pts with PsA managed by rheumatologist( n = 256)“ I worry that if I ask too many questions my healthcare professional will see healthcare professi-

“ I often tell my

me as a difficult patient and onal I am fine when it will affect the quality of I am really experiencing symptoms care I receive””

Disagree Agree n = 151 n = 105( 41 %)( 59 %) %

%

Agree n = 118( 46 %) %

Disagree n = 138( 54 %) %

Symptoms in past 12 months Joint pain Skin / nail symptoms Stiffness Joint swelling

85 83 74 70

P129 PSORIASIS PATIENTS POINT OF VIEW: WHAT ARE WE

MISSING WHEN MANAGING THEM? Elena Popa 1, Alexandra Brahas 2, Caius Solovan 1

1

Department of Dermatology and Venereology, Clinical Emergency City Hospital Timisoara; University of Medicine and Pharmacy“ Victor Babes” Timisoara, Romania, 2 University of Medicine and Pharmacy“ Victor Babes” Timisoara, Romania

Introduction: Psoriasis is a skin disease that can occur at any time and it is most common in the age group 50 – 69. The reported prevalence of Psoriasis in countries ranges between 0.09 % and 11.4 %, making it a serious global problem. Psoriasis affects the quality of life and it is associated with many comorbidities such as depression, diabetes, cardiovascular disease and psoriatic arthritis. To evaluate the severity and the efficiency of the treatment applied to patients with Psoriasis, in practice it is used PASI( Psoriasis Area and Severity Index). The value may vary, for example, in this study, PASI 75 represents the percentage( or number) of patients that have achieved a 75 % or more reduction in their PASI score in 12 weeks from baseline. Objectives: Aim of this study is to gain a better perspective on the Psoriasis patient’ s point of view when seeking a physician’ s

90 84 79 72

86 84 72 75 www. medicaljournals. se / acta